Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
28/09/2026 10:29
BRIEF-Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million Sept 28 (Reuters) - Natco Pharma Ltd NATP.NS:
NATCO PHARMA- TO INCREASE ITS INVESTMENT IN EGENESIS FROM $14.00 MILLION TO $16.70 MILLION THROUGH ITS UNITS
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees